Cannabidiol or CBD is a naturally occurring chemical compound in the cannabis plant that is used as an ingredient in various products to treat acne, menopause, anxiety and also functions as a lubricant to aid womens’ sex life. In all its forms, be it pills, capsules or oils, the compound does not get the consumer high as assumed since it does not contain the psychoactive compound THC, which is generally combined with marijuana.
CBD products are enticing to women because of the health benefits promised such as easing the mind simultaneously, alleviating sleep disorders and migraines, among other health concerns. Women indulge themselves in these controversial products because it is legal to do so.
With the passage of the Farm Bill in 2018, hemp containing about 0.3 percent of THC was legalized in the United States. This means that CBD products coming from a marijuana plant is illegal, but there is no way to accurately determine how much THC is contained in a cannabis plant and not all manufacturers disclose their content honestly.
Despite these concerns, a recent report by Brightfield Group estimates that the national CBD market will be worth $5 billion by the end of 2019. In other words, the market grew exponentially by 706 percent from the previous year.
Since the FDA is still trying to lay out the regulations of CBD in food products to prevent any grave consequences, especially among online retailers, manufacturers turned to the beauty industry since there were less risks involved. Skincare products considered for the purpose of the survey were CBD-infused lotions, balms and oils that are applied topically on the skin. Generally, not all CBD products are used topically.
For example, CBD anti-aging products are popular among women because they allegedly reduce dark spots and improve the skin’s appearance. “In general, anti-aging skin benefits may be related to the anti-inflammatory properties of CBD. Topical CBD is also great for skin rashes, eczema and psoriasis,” Anita Sadaty, obstetrician-gynecologist and founder of Redefining Health Medical in New York, said.
But the question of whether women can trust these products still remains, and researchers are trying to figure it out for the benefit of the public. A study published by JAMA Network on November 7, 2017, analyzed 84 products bought online from 31 different companies.
Of them, the researchers found that 36 of the products were under-labelled and 22 were over-labeled, while only 26 or 30 percent of these